PL3412673T3 - Sposób otrzymywania związku pirolo[3,2-d]pirymidynowego i jego produktów pośrednich - Google Patents

Sposób otrzymywania związku pirolo[3,2-d]pirymidynowego i jego produktów pośrednich

Info

Publication number
PL3412673T3
PL3412673T3 PL17747006T PL17747006T PL3412673T3 PL 3412673 T3 PL3412673 T3 PL 3412673T3 PL 17747006 T PL17747006 T PL 17747006T PL 17747006 T PL17747006 T PL 17747006T PL 3412673 T3 PL3412673 T3 PL 3412673T3
Authority
PL
Poland
Prior art keywords
intermediates
pyrimidine compound
preparing pyrrolo
pyrrolo
preparing
Prior art date
Application number
PL17747006T
Other languages
English (en)
Polish (pl)
Inventor
Zhaozhong DING
Fei Sun
Yinghu HU
Yilong ZHOU
Rui Zhao
Ling Yang
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co., Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co., Ltd
Publication of PL3412673T3 publication Critical patent/PL3412673T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL17747006T 2016-02-05 2017-02-04 Sposób otrzymywania związku pirolo[3,2-d]pirymidynowego i jego produktów pośrednich PL3412673T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
EP17747006.9A EP3412673B1 (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
PL3412673T3 true PL3412673T3 (pl) 2021-07-26

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17747006T PL3412673T3 (pl) 2016-02-05 2017-02-04 Sposób otrzymywania związku pirolo[3,2-d]pirymidynowego i jego produktów pośrednich

Country Status (28)

Country Link
US (2) US10654856B2 (cg-RX-API-DMAC10.html)
EP (1) EP3412673B1 (cg-RX-API-DMAC10.html)
JP (1) JP6877449B2 (cg-RX-API-DMAC10.html)
KR (1) KR102371500B1 (cg-RX-API-DMAC10.html)
CN (2) CN107043378A (cg-RX-API-DMAC10.html)
AR (1) AR107549A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017214134B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018015879B1 (cg-RX-API-DMAC10.html)
CA (1) CA3013520C (cg-RX-API-DMAC10.html)
CL (1) CL2018002094A1 (cg-RX-API-DMAC10.html)
DK (1) DK3412673T3 (cg-RX-API-DMAC10.html)
EA (1) EA034581B1 (cg-RX-API-DMAC10.html)
ES (1) ES2852323T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210103T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053455T2 (cg-RX-API-DMAC10.html)
IL (1) IL260999B (cg-RX-API-DMAC10.html)
LT (1) LT3412673T (cg-RX-API-DMAC10.html)
MX (1) MX374298B (cg-RX-API-DMAC10.html)
MY (1) MY190551A (cg-RX-API-DMAC10.html)
NZ (1) NZ744885A (cg-RX-API-DMAC10.html)
PH (1) PH12018501642A1 (cg-RX-API-DMAC10.html)
PL (1) PL3412673T3 (cg-RX-API-DMAC10.html)
PT (1) PT3412673T (cg-RX-API-DMAC10.html)
SG (1) SG11201806685VA (cg-RX-API-DMAC10.html)
SI (1) SI3412673T1 (cg-RX-API-DMAC10.html)
TW (1) TW201728590A (cg-RX-API-DMAC10.html)
UA (1) UA124100C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017133686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
MX386924B (es) * 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
JP6216387B2 (ja) * 2012-11-20 2017-10-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 新規化合物
SMT201700378T1 (it) * 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
WO2015168269A1 (en) * 2014-05-01 2015-11-05 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
KR102112192B1 (ko) * 2015-11-05 2020-05-19 치아타이 티안큉 파마수티컬 그룹 주식회사 Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途

Also Published As

Publication number Publication date
EP3412673B1 (en) 2020-11-25
HK1259183A1 (zh) 2019-11-29
LT3412673T (lt) 2021-03-10
IL260999B (en) 2021-02-28
BR112018015879B1 (pt) 2024-02-15
CN108602832B (zh) 2020-10-09
HUE053455T2 (hu) 2021-06-28
US10654856B2 (en) 2020-05-19
CA3013520A1 (en) 2017-08-10
HRP20210103T1 (hr) 2021-03-05
WO2017133686A1 (zh) 2017-08-10
JP6877449B2 (ja) 2021-05-26
PH12018501642B1 (en) 2019-06-03
CN107043378A (zh) 2017-08-15
KR102371500B1 (ko) 2022-03-07
AU2017214134B2 (en) 2020-08-27
UA124100C2 (uk) 2021-07-21
KR20180104724A (ko) 2018-09-21
EP3412673A4 (en) 2019-07-03
EP3412673A1 (en) 2018-12-12
BR112018015879A2 (pt) 2018-12-26
PH12018501642A1 (en) 2019-06-03
EA201891769A1 (ru) 2019-04-30
AU2017214134A1 (en) 2018-08-23
PT3412673T (pt) 2021-02-15
AR107549A1 (es) 2018-05-09
CA3013520C (en) 2022-07-19
ES2852323T3 (es) 2021-09-13
SG11201806685VA (en) 2018-09-27
US20190040072A1 (en) 2019-02-07
MY190551A (en) 2022-04-27
JP2019505531A (ja) 2019-02-28
CL2018002094A1 (es) 2018-12-07
US20200239484A1 (en) 2020-07-30
SI3412673T1 (sl) 2021-04-30
MX2018009502A (es) 2018-12-11
EA034581B1 (ru) 2020-02-21
MX374298B (es) 2025-03-06
NZ744885A (en) 2022-07-01
TW201728590A (zh) 2017-08-16
CN108602832A (zh) 2018-09-28
DK3412673T3 (da) 2021-01-18

Similar Documents

Publication Publication Date Title
IL288080A (en) A process for the preparation of h7-pyrrolo[3,2-d]pyrimidine derivatives and their artificial intermediates
IL260999B (en) A method for the preparation of a pyrrolo[3,2-d] pyrimidine compound, and its intermediates
IL255775B (en) A method for producing a derivative of h7-pyrrolo[3,2-d]pyrimidine and its intermediate
IL259169A (en) Novel pyrazolo pyrimidine derivatives
SG11201801365YA (en) NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUND OR SALT THEREOF
EP3260441A4 (en) Method for preparing formamide compound
ZA201800771B (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
EP3154970A4 (en) Pyrrolo[2,3-c]pyridines as imaging agents for neurofibrilary tangles
IL254224A0 (en) 7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors
ZA201807240B (en) Method for preparing azoxystrobin intermediates
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
EP3265455A4 (en) CHEMICAL PROCESS FOR THE PREPARATION OF PYRIMIDINE DERIVATIVES AND INTERMEDIATE PRODUCTS THEREOF
ZA201807239B (en) Method for preparing azoxystrobin
IL291114A (en) A pyrimidine compound and a method for its preparation
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
EP3276042A4 (en) Method for producing plated article
PL3436571T3 (pl) Sposób hodowli limfocytów B
EP3107542A4 (en) Process for preparing n-benzyl-3-hydroxy-4-substituted-pyridin-2-(1h)-ones
ZA201804871B (en) Process for preparing 7h-pyrrolo [2, 3-d] pyrimidine compounds
EP3368537A4 (en) METHOD FOR THE PRODUCTION OF IBRUTINIB AND ITS INTERMEDIATE PRODUCTS
IL259557A (en) Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine
EP3262025A4 (en) Novel intermediates for preparing dpp-iv inhibitors, preparing method thereof and preparing method of dpp-iv inhibitors using the same
EP3543237A4 (en) SIMPLE MANUFACTURING METHOD FOR AN AVIBACTAM INTERMEDIATE
GB201600977D0 (en) Novel crystalline form of picoxystrobin, method of preparing use of the same
EP3224257A4 (en) Novel method for preparing thienopyrimidine compound and intermediates used therein